KLRK1 and melanoma: Moreover, we demonstrated that the addition of 1MT or rofecoxib to melanoma/iNKT cell co-cultures partially restored both NKG2D-mediated (Figure 9A) and TCR-mediated iNKT cell cytotoxicity (Figure 8B).